CHICAGO – GATC Health, a startup company that focuses on omics-based disease risk prediction, has been expanding the reach of its Multiomics Advanced Technology (MAT) bioinformatics platform.
The company, which is distinct from GATC Biotech, a German sequencing services firm that was acquired by Eurofins in 2017, is less than a year old, but the underlying technology has been around for more than a decade — and has its roots in medical marijuana.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
